Results were slightly above prior year but revenue was flat and no guidance was provided. The stock may trade sideways. Watch for completion of the Miller Medical Plaza development (expected Q4 2026) as a potential catalyst.
Price Chart
Executive Summary
UHT reported Q1 2026 net income of $5.0M ($0.36/diluted share), up from $4.8M ($0.34) a year ago, driven by lower interest expense. FFO increased to $0.88/diluted share from $0.86. Revenue was essentially flat at $24.5M. The modest beat lacked guidance, so the report is unlikely to move the stock significantly.
Key Financial Metrics
Key Facts
- Q1 2026 net income $5.0M vs $4.8M in Q1 2025
- FFO per diluted share $0.88 vs $0.86 year-over-year
- Revenue $24.5M, virtually unchanged from $24.5M
- Quarterly dividend maintained at $0.745 per share
- Credit line increased to $475M from $425M in April 2026
Financial Impact
Net income up $242K (5.1%), FFO up $336K (2.3%), revenue down $19K (0.1%)
Risk Factors
- Interest rate increases could pressure borrowing costs
- Healthcare policy changes (Medicaid funding) may affect tenant operations
- Concentration risk with UHS as a major tenant
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-182162 |
| Document: uht-20260427.htm | 0001193125-26-182162 |
| Document: 0001193125-26-182162-index-headers.html | 0001193125-26-182162 |
| Document: 0001193125-26-182162-index.html | 0001193125-26-182162 |
| Document: 0001193125-26-182162.txt | 0001193125-26-182162 |
| 8-K Data (Synthetic) | 0001193125-26-182162 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 28, 2026 22w ago | DEFA14A | $40.80 $43.29 | ▲ +6.10% | ▲ +2.11% | $36.60 (−10.29%) |
Apr 27, 2026 22w ago | 8-K | $40.80 $43.29 | ▲ +6.10% | ▲ +2.11% | $36.60 (−10.29%) |
Apr 24, 2026 23w ago | 8-K | $40.77 $43.88 | ▲ +7.63% | ▲ +2.55% | $36.60 (−10.23%) |
Feb 25, 2026 31w ago | 8-K | $43.38 $42.12 | ▲ +2.90% | ▲ +10.65% | $36.60 (+15.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access